Clinical trial
The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus…
NCT00402207 · Maastricht University Medical Center, Other · Completed
Key facts
| NCT number | NCT00402207 |
|---|---|
| Title | The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry |
| Official title | The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Exhaled Nitric Oxide, Inflammatory Markers in Exhaled Breath Condensate and Conventional Parameters |
| Lead sponsor | Maastricht University Medical Center, Other |
| Collaborators | AstraZeneca Industry Teva Branded |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | extrafine HFA-beclomethasone, HFA-fluticasone |
| Enrollment | 33 |
| Start date | Aug 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Nov 22, 2006 |
| Last update posted | Nov 22, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: